The Globe and Mail reports in its Saturday, May 6, edition that BMO Capital Markets analyst Thanos Moschopoulos has reaffirmed his "outperform" recommendation for Kinaxis. The Globe's David Leeder writes in the Eye On Equities column that Mr. Moschopoulos boosted his share target ahead by $5 to $205. Analysts on average target the shares at $220. Mr. Moschopoulos says in a note: "Results were in line on total revenue, a modest beat on SaaS revenue and a hair light on EBITDA, while management raised FY2023 revenue guidance by 1 per cent and EBITDA guidance by 8 per cent. We believe the stock's valuation remains attractive relative to enterprise SaaS peers given Kinaxis's growth rate, competitive position, and consistent execution. Further, the results support our view that Kinaxis's end market will prove to be more macro-resilient than other pockets of enterprise software." The Globe reported on Dec. 13 that CIBC analyst Stephanie Price had called Kinaxis an "outperformer." The shares could then be had for $154. The Globe reported on March 6 that Scotia Capital analyst Kevin Krishnaratne was sticking with his "sector outperform" call for Kinaxis, which could then be had for $171.10.